No Cover Image

Journal article 522 views 2 downloads

A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care

Sofia Taverner Orcid Logo, Cindy Eng, Rebecca Watson, Siba George, Amanda Edwards, David M. Williams, Jeffrey Stephens Orcid Logo

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Volume: 16, Issue: 12, Start page: 102658

Swansea University Author: Jeffrey Stephens Orcid Logo

  • DKA associated with SGLT2i Accepted manuscript, complete.pdf

    PDF | Accepted Manuscript

    ©2022 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)

    Download (95.04KB)

Check full text

DOI (Published version): 10.1016/j.dsx.2022.102658

Published in: Diabetes and Metabolic Syndrome: Clinical Research and Reviews
ISSN: 1871-4021
Published: Elsevier BV 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa61828
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2022-11-09T11:24:45Z
last_indexed 2023-01-13T19:22:51Z
id cronfa61828
recordtype SURis
fullrecord <?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>61828</id><entry>2022-11-09</entry><title>A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care</title><swanseaauthors><author><sid>5219d126f97f8f884bdb622099bd41de</sid><ORCID>0000-0003-2228-086X</ORCID><firstname>Jeffrey</firstname><surname>Stephens</surname><name>Jeffrey Stephens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-11-09</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes and Metabolic Syndrome: Clinical Research and Reviews</journal><volume>16</volume><journalNumber>12</journalNumber><paginationStart>102658</paginationStart><paginationEnd/><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1871-4021</issnPrint><issnElectronic/><keywords>Dapagliflozin; Empagliflozin; Canagliflozin; SGLT2 inhibitor</keywords><publishedDay>1</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-12-01</publishedDate><doi>10.1016/j.dsx.2022.102658</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Not Required</apcterm><funders>No funding was required for this work.</funders><projectreference/><lastEdited>2024-07-17T15:34:20.0675593</lastEdited><Created>2022-11-09T11:22:41.1818569</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Sofia</firstname><surname>Taverner</surname><orcid>0000-0002-1216-7188</orcid><order>1</order></author><author><firstname>Cindy</firstname><surname>Eng</surname><order>2</order></author><author><firstname>Rebecca</firstname><surname>Watson</surname><order>3</order></author><author><firstname>Siba</firstname><surname>George</surname><order>4</order></author><author><firstname>Amanda</firstname><surname>Edwards</surname><order>5</order></author><author><firstname>David M.</firstname><surname>Williams</surname><order>6</order></author><author><firstname>Jeffrey</firstname><surname>Stephens</surname><orcid>0000-0003-2228-086X</orcid><order>7</order></author></authors><documents><document><filename>61828__25919__8817c4ee48a64de8b37b9f7bfda43f9c.pdf</filename><originalFilename>DKA associated with SGLT2i Accepted manuscript, complete.pdf</originalFilename><uploaded>2022-11-28T09:26:25.2652718</uploaded><type>Output</type><contentLength>97318</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2023-11-02T00:00:00.0000000</embargoDate><documentNotes>©2022 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by-nc-nd/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling v2 61828 2022-11-09 A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care 5219d126f97f8f884bdb622099bd41de 0000-0003-2228-086X Jeffrey Stephens Jeffrey Stephens true false 2022-11-09 MEDS Journal Article Diabetes and Metabolic Syndrome: Clinical Research and Reviews 16 12 102658 Elsevier BV 1871-4021 Dapagliflozin; Empagliflozin; Canagliflozin; SGLT2 inhibitor 1 12 2022 2022-12-01 10.1016/j.dsx.2022.102658 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Not Required No funding was required for this work. 2024-07-17T15:34:20.0675593 2022-11-09T11:22:41.1818569 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Sofia Taverner 0000-0002-1216-7188 1 Cindy Eng 2 Rebecca Watson 3 Siba George 4 Amanda Edwards 5 David M. Williams 6 Jeffrey Stephens 0000-0003-2228-086X 7 61828__25919__8817c4ee48a64de8b37b9f7bfda43f9c.pdf DKA associated with SGLT2i Accepted manuscript, complete.pdf 2022-11-28T09:26:25.2652718 Output 97318 application/pdf Accepted Manuscript true 2023-11-02T00:00:00.0000000 ©2022 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND) true eng https://creativecommons.org/licenses/by-nc-nd/4.0/
title A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
spellingShingle A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
Jeffrey Stephens
title_short A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
title_full A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
title_fullStr A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
title_full_unstemmed A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
title_sort A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
author_id_str_mv 5219d126f97f8f884bdb622099bd41de
author_id_fullname_str_mv 5219d126f97f8f884bdb622099bd41de_***_Jeffrey Stephens
author Jeffrey Stephens
author2 Sofia Taverner
Cindy Eng
Rebecca Watson
Siba George
Amanda Edwards
David M. Williams
Jeffrey Stephens
format Journal article
container_title Diabetes and Metabolic Syndrome: Clinical Research and Reviews
container_volume 16
container_issue 12
container_start_page 102658
publishDate 2022
institution Swansea University
issn 1871-4021
doi_str_mv 10.1016/j.dsx.2022.102658
publisher Elsevier BV
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2022-12-01T15:34:18Z
_version_ 1804837174399467520
score 11.017731

Similar Items